Judge Allows Pfizer, Moderna Defenses In GSK Vax IP Dispute

By Adam Lidgett · June 16, 2026, 6:17 PM EDT

A Delaware federal judge on Tuesday permitted Pfizer and Moderna to move ahead with their arguments that GlaxoSmithKline patents the company claims are infringed by the COVID-19 vaccines are unenforceable because...

To view the full article, register now.

Documents

Case Information

Case Title

GlaxoSmithKline Biologicals SA et al v. Pfizer Inc. et al

Case Number

1:24-cv-00512

Court

Delaware

Nature of Suit

Patent

Date Filed

April 25, 2024


Case Title

GlaxoSmithKline Biologicals SA et al v. Moderna, Inc. et al

Case Number

1:24-cv-01135

Court

Delaware

Nature of Suit

Patent

Date Filed

October 12, 2024